Arlington Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.56M Buy
66,078
+16,733
+34% +$1.15M 1.68% 19
2025
Q1
$3.43M Buy
49,345
+19,933
+68% +$1.38M 1.34% 54
2024
Q4
$2.53M Hold
29,412
0.98% 50
2024
Q3
$3.5M Buy
29,412
+5,935
+25% +$707K 1.37% 56
2024
Q2
$3.35M Sell
23,477
-3,680
-14% -$525K 1.66% 12
2024
Q1
$3.49M Sell
27,157
-3,018
-10% -$388K 1.78% 12
2023
Q4
$3.12M Sell
30,175
-1,177
-4% -$122K 0.9% 32
2023
Q3
$2.85M Buy
31,352
+3,930
+14% +$357K 1.17% 26
2023
Q2
$2.22M Hold
27,422
0.34% 30
2023
Q1
$2.18M Sell
27,422
-12,550
-31% -$999K 0.31% 28
2022
Q4
$2.7M Hold
39,972
0.43% 24
2022
Q3
$1.99M Buy
39,972
+646
+2% +$32.2K 0.8% 28
2022
Q2
$2.19M Sell
39,326
-9,984
-20% -$556K 0.73% 27
2022
Q1
$2.74M Sell
49,310
-7,352
-13% -$408K 0.77% 27
2021
Q4
$3.17M Sell
56,662
-7,914
-12% -$443K 0.85% 23
2021
Q3
$3.1M Sell
64,576
-21,288
-25% -$1.02M 0.89% 25
2021
Q2
$3.6M Buy
85,864
+2,006
+2% +$84K 1.25% 17
2021
Q1
$2.83M Buy
83,858
+12,970
+18% +$437K 1.03% 18
2020
Q4
$2.48M Buy
70,888
+836
+1% +$29.2K 1.14% 18
2020
Q3
$2.43M Hold
70,052
1.33% 16
2020
Q2
$2.29M Sell
70,052
-7,050
-9% -$231K 1.29% 19
2020
Q1
$2.32M Buy
77,102
+61,732
+402% +$1.86M 1.21% 18
2019
Q4
$445K Buy
15,370
+3,440
+29% +$99.6K 0.27% 30
2019
Q3
$308K Sell
11,930
-84,370
-88% -$2.18M 0.2% 38
2019
Q2
$2.46M Buy
96,300
+86,380
+871% +$2.2M 1.1% 21
2019
Q1
$259K Sell
9,920
-45,980
-82% -$1.2M 0.19% 50
2018
Q4
$1.29M Buy
55,900
+1,380
+3% +$31.8K 0.84% 22
2018
Q3
$1.29M Buy
54,520
+760
+1% +$17.9K 0.9% 25
2018
Q2
$1.24M Hold
53,760
1.17% 19
2018
Q1
$1.32M Buy
53,760
+3,850
+8% +$94.8K 1.25% 19
2017
Q4
$1.34M Buy
+49,910
New +$1.34M 1.38% 19